ELRIG Drug Discovery is the premier meeting place in Europe for scientists from industry, biotech and academia engaged in pre-clinical drug discovery. First established in Nottingham in 2006, the meeting this year expects over 1,200 delegates and 80 exhibiting companies, bringing together world-leading scientists to discuss cutting-edge advances in the application of laboratory technology, disease biology and development of novel chemical and biological candidate drugs.
The 2016 program will include exciting sessions on the development of new medicines in oncology and immunotherapy, the application of innovative technologies in assay development, drug screening and chemistry and the application of new technologies to identify and validate drug targets. New for this year is a track discussing ground-breaking developments in the use of cells as biological tools and therapeutics.
In the ten years since the first Drug Discovery meeting, the industry has grown exponentially, with technological advances in early drug discovery and its clinical applications putting life sciences at the epicentre of drug and gene therapies. Through collaborations with experts from industry and academia along with the backing of some global pharmaceutical organisations, ELRIG continues to provide free-to-attend meetings which are accessible to all.
Full details of the event can be found here.
“Through my involvement with ELRIG over the past ten years I have seen many changes in the industry, and within ELRIG. While the science and vision of ELRIG have evolved, the underpinning values of the organisation have not and we continually adapt to meet the needs of our members whilst maintaining integrity,” said ELRIG chairman Sanj Kumar. He continued: “ELRIG’s growth from a small gathering of like-minded individuals to hosts of the largest drug discovery event in Europe in itself speaks volumes for the hard work, dedication and enthusiasm of the team. I am immensely proud of what we have achieved and look forward to celebrating the 10th anniversary of Drug Discovery with our most inspiring meeting yet.”
Steve Rees, VP Screening Sciences and Sample Management at AstraZeneca commented: “I was delighted to act as Program Chair for the first six Drug Discovery Meetings. The quality of the scientific presentations together with the opportunity to engage with colleagues from across the field, and to view the largest vendor exhibition of its type in Europe, makes this a must attend event. I look forward to the meeting in Liverpool as ELRIG continues its mission to provide freely accessible high quality scientific content and networking opportunities to the scientific community.”
To register, submit a poster abstract or book an exhibition stand, please visit the Drug Discovery 2016 page of the ELRIG website.
Follow ELRIG on Twitter (@ELRIG_UK) and LinkedIn for updates on this event, and more. The Twitter hashtag for Drug Discovery 2016 is #ELRIGDD16